Ventricular assist device as a bridge to transplant in patients with cardiogenic shock. Report of four patients;Asistencia ventricular mecánica como puente al trasplante en pacientes en shock cardiogénico: Experiencia preliminar en Chile con ABIOMED BVS 5000®

Revista Medica de Chile

Volumn 134, Issue 8, 2006, Pages 1019-1023

  Castro G, Pablo ^a   Baraona R, Fernando ^a   Baeza P, Cristian ^a   Mc Nab M, Paul ^a   Berlin R, Alejandro ^a   Zalaquett S, Ricardo ^a   Morán V, Sergio ^a   Becker R, Pedro ^a   Irarrázabal LI, Manuel ^a   Garayar P, Bernardita ^a   Carvajal T, Mario ^a   Cisternas Y, Sergio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Cardiogenic; Congestive; Heart failure; Heart transplantation; Shock

Indexed keywords

ADULT; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; CHILE; CONGESTIVE HEART FAILURE; EQUIPMENT DESIGN; FATALITY; FEMALE; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HUMAN; MALE; MIDDLE AGED;

ADULT; CHILE; EQUIPMENT DESIGN; FATAL OUTCOME; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; SHOCK, CARDIOGENIC;

EID: 33751291721     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: 6A-13A.
2. Castro P, Vukasovic JL, Garcés E, Sepúlveda L, Ferrada M, Alvarado S. Cardiac failure in Chilean hospitals: results of the National Registry of Heart Failure, ICARO. Rev Méd Chile 2004; 132: 655-62.
3. Morán S, Castro P, Zalaquett R, Becker P, Garayar B, Irarrázaval MJ et al. Tratamiento de la insuficiencia cardiaca avanzada mediante trasplante de corazón. Rev Méd Chile 2001; 129: 9-17.
4. Marelli D, Laks H, Amsel B, Jett Gk, Couper G, Ardehali A et al. Temporary mechanical support with the BVS 5000 Assist Device during treatment of acute myocarditis. J Card Surg 1997; 12: 55-9.
5. Hetzer R, Muller JH, Weng Y, Meyer R, Dandel M. Bridging to recovery. Ann Thorac Surg 2001; 71: S109-13.
6. Goldstein DJ, Zucker M, Arroyo L, Baran D, Mccarthy PM, Loebe M et al. Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation. J Am Coll Cardiol 2005; 45: 962-3.
7. Noon GP, Morley DL, Irwin S, Abdelsayed SV, Benkowski RJ, Lynch BE. Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg 2001; 71(3 Suppl): S133-8.
8. Dagenais F, Portner PM, Robbins RC, Oyer PE. The Novacor left ventricular assist system: clinical experience from the Novacor registry. J Card Surg 2001; 16: 267-71.
9. Dekkers RJ, Fitzgerald DJ, Couper GS. Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure. Perfusion 2001; 16: 13-8.
10. Holman WL, Bourge RC, Spruell RD, Murrah CP, McGiffin DC, Kirklin JK. Ventricular assist devices as a bridge to cardiac transplantation: a prelude to destination therapy. Ann Surg 1997; 225: 695-704.
11. Arabia FA, Smith RG, Rose DS. Success rates of long-term circulatory assist devices used currently for bridge to heart transplantation. ASAIO J 1996; 42: M542-6.
12. Despotis GJ, Levine V, Joist H, Santoro SA, Mendeloff E. Multiple episodes of thrombosis with biventricular support devices with inadequate anticoagulation and evidence of accelerated intravascular coagulation. J Thorac Cardiovasc Surg 1997; 113: 419-22.
13. Lazar R, Shapiro P, Jaski B, Parides M, Bourge R, Watson J et al. Neurological events during long-term mechanical circulatory support for heart failure the randomized evaluation of mechanical assistance for the treatment of congestive heart failure (REMATCH) Experience. Circulation 2004; 109: 2423-7.
14. Slater JP, Rose EA, Levin HR, Frazier OH, Roberts JK, Weinberg AD et al. Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg 1996; 62: 1321-7.
15. Spanier T, Oz M, Levin H, Weinberg A, Stamatis K, Stern D et al. Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg 1996; 112: 1090-7.
16. Argenziano M, Catanese KA, Moazami N, Gardocki MT, Weinberg AD, Clavenna MW et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant 1997; 16: 822-31.
17. Simon D, Fischer S, Grossman A, Downer C, Hota B, Heroux A et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis 2005; 40: 1108-15.
18. Ziv O, Dizon J, Thosani A, Naka Y, Magnano A, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol 2005; 45: 1428-34.
19. Dekkers R, Fitzgerald D, Couper G. Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure. Perfusion 2001; 16: 13-8.
20. Morgan JA, Stewart AS, Lee BJ, Oz MC, Naka Y. Role of the Abiomed BVS 5000 device for short-term support and bridge to transplantation. ASAIO J 2004; 50: 360-3.